| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,597 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,596 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,071 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,375 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,033 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
608 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7479478 |
Human parathyroid hormone modifications, preparation and use |
Jan. 20, 2009 |
| 7479283 |
Acellular pertussis vaccine comprising a combination of the 69 kDa and the filamentous haemagglutinin antigens of Bordetella pertussis |
Jan. 20, 2009 |
| 7479282 |
Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
Jan. 20, 2009 |
| 7479281 |
Botulinum toxin for treating postherpetic neuralgia |
Jan. 20, 2009 |
| 7479275 |
Method of administering and using VEGF inhibitors for the treatment of colorectal cancer |
Jan. 20, 2009 |
| 7479274 |
Method of administering and using VEGF inhibitors for the treatment of pancreatic carcinoma |
Jan. 20, 2009 |
| 7479273 |
Method of administering and using VEGF inhibitors for the treatment of renal cell cancer |
Jan. 20, 2009 |
| 7479272 |
Method of administering and using VEGF inhibitors for the treatment of breast cancer |
Jan. 20, 2009 |
| 7476651 |
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |
Jan. 13, 2009 |
| 7476650 |
Enzyme inhibition |
Jan. 13, 2009 |
| 7476649 |
Antiproliferative and antiviral proteins and peptides |
Jan. 13, 2009 |
| 7476648 |
Vessel embolic material comprising hydrogel and therapy with the use thereof |
Jan. 13, 2009 |
| 7476388 |
Composition comprising a gastrin/CCK receptor ligand and an EGF receptor ligand |
Jan. 13, 2009 |
| 7473682 |
Angiogenic peptides and uses thereof |
Jan. 6, 2009 |
| 7473679 |
Treatments employing neuronal exocytosis-inhibiting peptides |
Jan. 6, 2009 |
| 7473678 |
Platelet-derived growth factor compositions and methods of use thereof |
Jan. 6, 2009 |
| 7470674 |
Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
Dec. 30, 2008 |
| 7470666 |
Use of Ulinastatin and its pharmaceutical composition for treating severe acute respiratory syndrome |
Dec. 30, 2008 |
| 7470662 |
Method of reducing the likelihood of implantation failure during an assisted reproduction in a female subject in a need thereof |
Dec. 30, 2008 |
| 7470661 |
Delivery of superoxide dismutase to neuronal cells |
Dec. 30, 2008 |
| 7470660 |
Treatment for dark adaptation |
Dec. 30, 2008 |
| 7470659 |
Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) |
Dec. 30, 2008 |
| 7470658 |
Methods for inhibiting tumor metastasis, and peptides useful therefor |
Dec. 30, 2008 |
| 7470428 |
Compositions and methods related to TIM-3, a Th1-specific cell surface molecule |
Dec. 30, 2008 |
| 7468350 |
Glue composition for lung volume reduction |
Dec. 23, 2008 |
| 7468193 |
Nutritional composition against side effects of chemotherapy or radiotherapy |
Dec. 23, 2008 |
| 7468189 |
Neuropathic pain treatment method |
Dec. 23, 2008 |
| 7465734 |
Methods and compositions for overcoming resistance to biologic and chemotherapy |
Dec. 16, 2008 |
| 7465710 |
Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm |
Dec. 16, 2008 |
| 7465707 |
Methods of treatment with TR10 polypeptides |
Dec. 16, 2008 |
| 7465706 |
GDF3 propeptides and related methods |
Dec. 16, 2008 |
| 7465705 |
Nogo receptor antagonists |
Dec. 16, 2008 |
| 7465703 |
Methods and kits useful for guiding osteoporosis related therapy |
Dec. 16, 2008 |
| 7462598 |
Antimicrobial theta defensins, analogs thereof, and methods of use |
Dec. 9, 2008 |
| 7462595 |
Methods for treating cancer-related fatigue |
Dec. 9, 2008 |
| 7462594 |
Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases |
Dec. 9, 2008 |
| 7462593 |
Compositions and methods for promoting angiogenesis |
Dec. 9, 2008 |
| 7462592 |
Compositions and methods for polynucleotide delivery |
Dec. 9, 2008 |
| 7462489 |
Methods for identifying and analyzing biomarkers from plasma-derived microparticles |
Dec. 9, 2008 |
| 7462472 |
Methods and compositions relating to anthrax pathogenesis |
Dec. 9, 2008 |
| 7462365 |
Microencapsulation and sustained release of biologically active polypeptides |
Dec. 9, 2008 |
| 7462357 |
Compounds and methods for treatment and diagnosis of chlamydial infection |
Dec. 9, 2008 |
| 7462350 |
Cancer treatments including administering IL-2 fusion proteins with modulated selectivity |
Dec. 9, 2008 |
| 7462349 |
Beta interferon for the treatment of chronic spinal cord injury |
Dec. 9, 2008 |
| 7459440 |
Ocular tear growth factor-like protein |
Dec. 2, 2008 |
| 7459436 |
Treatment of disturbances of iron distribution |
Dec. 2, 2008 |
| 7459435 |
Treatment of disturbances of iron distribution |
Dec. 2, 2008 |
| 7459433 |
Homotrimeric extended OBG3 globular head and uses thereof |
Dec. 2, 2008 |
| 7459429 |
Method of treating disturbances of iron distribution in inflammatory intestinal diseases |
Dec. 2, 2008 |
| 7459428 |
Method of regulating glucose metabolism, and reagents related thereto |
Dec. 2, 2008 |
|
|
|
